Evidence map›Paper›PMID 40405662›Full record

ArticleJournal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG2025

Atypical infections during combination therapy with anifrolumab and other immunosuppressives in patients with lupus erythematosus: A case series.

Shae Chambers, Lais Lopes Almeida Gomes, Xiwei Yang, Aretha On, Hammad Ali, Touraj Khosravi-Hafshejani, Kimberly DeQuattro, Preethi Thomas, Victoria P Werth

Abstract readCase Reports
In one paragraph

Article in Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. [Biologics and infections: understand and recognize].Dermatologie (Heidelberg, Germany) · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shae ChambersDepartment of Dermatology, Perelman SchoAmerican Academy of Dermatology and Society of Investigative Dermatologyol of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID https://orcid.org/0009-0005-1893-157X
Lais Lopes Almeida GomesDepartment of Dermatology, Perelman SchoAmerican Academy of Dermatology and Society of Investigative Dermatologyol of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Xiwei YangDepartment of Dermatology, Perelman SchoAmerican Academy of Dermatology and Society of Investigative Dermatologyol of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Aretha OnDepartment of Dermatology, Perelman SchoAmerican Academy of Dermatology and Society of Investigative Dermatologyol of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Hammad AliDepartment of Dermatology, Perelman SchoAmerican Academy of Dermatology and Society of Investigative Dermatologyol of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Touraj Khosravi-HafshejaniDepartment of Dermatology, Perelman SchoAmerican Academy of Dermatology and Society of Investigative Dermatologyol of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Kimberly DeQuattroDepartment of Medicine, Division of Rheumatology, University of Pennsylvania Philadelphia, PA, USA.
Preethi ThomasDepartment of Medicine, Division of Rheumatology, University of Pennsylvania Philadelphia, PA, USA.
Victoria P WerthDepartment of Dermatology, Perelman SchoAmerican Academy of Dermatology and Society of Investigative Dermatologyol of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Funding

Optimization of Clinical Trial Design in Cutaneous LupusR01AR071653 · NIAMS · UT SOUTHWESTERN MEDICAL CENTER · PI CHONG, BENJAMIN FRANKLIN, WERTH, VICTORIA P · 2018 to 2020
$653k
BLRD VA I01 BX005921NIAMS NIH HHS R01 AR071653
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anifrolumabAutoimmune skin diseasecutaneous lupus erythematosusmedical dermatologysystemic lupus erythematosus

Identifiers

PMID40405662
PMCPMC12435148

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.